These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24197277)

  • 61. The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study.
    Zhu J; Wang H; Liu CC; Lu Y; Tang H
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2339-45. PubMed ID: 27566683
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3327-31. PubMed ID: 24272203
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-α levels predict the progression of colorectal cancer.
    Chang PH; Pan YP; Fan CW; Tseng WK; Huang JS; Wu TH; Chou WC; Wang CH; Yeh KY
    Cancer Med; 2016 Mar; 5(3):426-33. PubMed ID: 26799163
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries.
    González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
    Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts.
    van der Zee AG; de Cuyper EM; Limburg PC; de Bruijn HW; Hollema H; Bijzet J; Krans M; de Vries EG
    Cancer; 1995 Feb; 75(4):1004-9. PubMed ID: 7842401
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma.
    Xie X; Ye D; Chen H; Lu W; Cheng B; Zhong H
    Int J Gynaecol Obstet; 2004 May; 85(2):151-8. PubMed ID: 15099777
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.
    Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
    Oncotarget; 2015 Sep; 6(29):28491-501. PubMed ID: 26143638
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer.
    Allensworth SK; Langstraat CL; Martin JR; Lemens MA; McGree ME; Weaver AL; Dowdy SC; Podratz KC; Bakkum-Gamez JN
    Gynecol Oncol; 2013 Sep; 130(3):499-504. PubMed ID: 23747328
    [TBL] [Abstract][Full Text] [Related]  

  • 69. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3095-102. PubMed ID: 24307621
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer.
    Yang Z; Shen H; He W; Ouyang L; Guo Y; Qian F; Xu B; Xie D; Yang G
    Tohoku J Exp Med; 2018 Jul; 245(3):141-148. PubMed ID: 29962380
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery.
    Paulsen T; Kærn J; Tropé C
    Gynecol Oncol; 2011 Jul; 122(1):83-8. PubMed ID: 21435701
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer.
    Dobrzycka B; Terlikowski SJ; Kowalczuk O; Kinalski M
    Eur Cytokine Netw; 2009 Sep; 20(3):131-4. PubMed ID: 19825522
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.
    Xie X; Yang M; Ding Y; Yu L; Chen J
    Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.
    Ma X; Wang Y; Sheng H; Tian W; Qi Z; Teng F; Xue F
    J Obstet Gynaecol Res; 2014 Jan; 40(1):178-83. PubMed ID: 24102732
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
    Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.
    Nikiteas NI; Tzanakis N; Gazouli M; Rallis G; Daniilidis K; Theodoropoulos G; Kostakis A; Peros G
    World J Gastroenterol; 2005 Mar; 11(11):1639-43. PubMed ID: 15786541
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients.
    Ravishankaran P; Karunanithi R
    World J Surg Oncol; 2011 Feb; 9():18. PubMed ID: 21294915
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevated Th22 cells and related cytokines in patients with epithelial ovarian cancer.
    Wang T; Zhang Z; Xing H; Wang L; Zhang G; Yu N; Wang J; Guo W; Jiang J
    Medicine (Baltimore); 2017 Oct; 96(43):e8359. PubMed ID: 29069020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.